These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21692501)

  • 1. Structure-activity relationships of GHRP-6 azapeptide ligands of the CD36 scavenger receptor by solid-phase submonomer azapeptide synthesis.
    Sabatino D; Proulx C; Pohankova P; Ong H; Lubell WD
    J Am Chem Soc; 2011 Aug; 133(32):12493-506. PubMed ID: 21692501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azapeptide Synthesis Methods for Expanding Side-Chain Diversity for Biomedical Applications.
    Chingle R; Proulx C; Lubell WD
    Acc Chem Res; 2017 Jul; 50(7):1541-1556. PubMed ID: 28598597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring side-chain diversity by submonomer solid-phase aza-peptide synthesis.
    Sabatino D; Proulx C; Klocek S; Bourguet CB; Boeglin D; Ong H; Lubell WD
    Org Lett; 2009 Aug; 11(16):3650-3. PubMed ID: 19606817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azapeptide analogues of the growth hormone releasing peptide 6 as cluster of differentiation 36 receptor ligands with reduced affinity for the growth hormone secretagogue receptor 1a.
    Proulx C; Picard É; Boeglin D; Pohankova P; Chemtob S; Ong H; Lubell WD
    J Med Chem; 2012 Jul; 55(14):6502-11. PubMed ID: 22712585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Submonomer synthesis of azapeptide ligands of the Insulin Receptor Tyrosine Kinase domain.
    Kurian LA; Silva TA; Sabatino D
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4176-80. PubMed ID: 25127870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influences of Histidine-1 and Azaphenylalanine-4 on the Affinity, Anti-inflammatory, and Antiangiogenic Activities of Azapeptide Cluster of Differentiation 36 Receptor Modulators.
    Chignen Possi K; Mulumba M; Omri S; Garcia-Ramos Y; Tahiri H; Chemtob S; Ong H; Lubell WD
    J Med Chem; 2017 Nov; 60(22):9263-9274. PubMed ID: 29028172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atheroprotective and atheroregressive potential of azapeptide derivatives of GHRP-6 as selective CD36 ligands in apolipoprotein E-deficient mice.
    Frégeau G; Sarduy R; Elimam H; Esposito CL; Mellal K; Ménard L; Leitão da Graça SD; Proulx C; Zhang J; Febbraio M; Soto Y; Lubell WD; Ong H; Marleau S
    Atherosclerosis; 2020 Aug; 307():52-62. PubMed ID: 32721647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity-Oriented Synthesis of Cyclic Azapeptides by A
    Zhang J; Mulumba M; Ong H; Lubell WD
    Angew Chem Int Ed Engl; 2017 May; 56(22):6284-6288. PubMed ID: 28090719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid phase submonomer azapeptide synthesis.
    Bowles M; Proulx C
    Methods Enzymol; 2021; 656():169-190. PubMed ID: 34325786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study.
    Demers A; McNicoll N; Febbraio M; Servant M; Marleau S; Silverstein R; Ong H
    Biochem J; 2004 Sep; 382(Pt 2):417-24. PubMed ID: 15176951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aza-amino acid scanning of chromobox homolog 7 (CBX7) ligands.
    Traoré M; Gignac M; Doan ND; Hof F; Lubell WD
    J Pept Sci; 2017 Apr; 23(4):266-271. PubMed ID: 28220557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity-oriented synthesis of azapeptides with basic amino acid residues: aza-lysine, aza-ornithine, and aza-arginine.
    Traoré M; Doan ND; Lubell WD
    Org Lett; 2014 Jul; 16(13):3588-91. PubMed ID: 24959890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic aza-peptide integrin ligand synthesis and biological activity.
    Spiegel J; Mas-Moruno C; Kessler H; Lubell WD
    J Org Chem; 2012 Jun; 77(12):5271-8. PubMed ID: 22582818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of novel azapeptide activators of apoptosis mediated by caspase-9 in cancer cells.
    Bourguet CB; Boulay PL; Claing A; Lubell WD
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3361-5. PubMed ID: 24986663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Biomedical Potential of Azapeptide Modulators of the Cluster of Differentiation 36 Receptor (CD36).
    Proulx C; Zhang J; Sabatino D; Chemtob S; Ong H; Lubell WD
    Biomedicines; 2020 Jul; 8(8):. PubMed ID: 32717955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aza-amino acid scanning of secondary structure suited for solid-phase peptide synthesis with fmoc chemistry and aza-amino acids with heteroatomic side chains.
    Boeglin D; Lubell WD
    J Comb Chem; 2005; 7(6):864-78. PubMed ID: 16283795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azapeptides and their therapeutic potential.
    Proulx C; Sabatino D; Hopewell R; Spiegel J; García Ramos Y; Lubell WD
    Future Med Chem; 2011 Jul; 3(9):1139-64. PubMed ID: 21806378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synthesis of azapeptidomimetic beta-lactam molecules as potential protease inhibitors.
    Malachowski WP; Tie C; Wang K; Broadrup RL
    J Org Chem; 2002 Dec; 67(25):8962-9. PubMed ID: 12467415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New m-calpain substrate-based azapeptide inhibitors.
    Bánóczi Z; Tantos Á; Farkas A; Majer Z; Dókus LE; Tompa P; Hudecz F
    J Pept Sci; 2013 Jun; 19(6):370-6. PubMed ID: 23613308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azapeptides as pharmacological agents.
    Zega A
    Curr Med Chem; 2005; 12(5):589-97. PubMed ID: 15777214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.